Bluejay Diagnostics (BJDX)

• Market cap: $4.98M
• 1 day: -1.64%
• 5 days: -13.95%
• 1 month: 188.02%
• 3 months: 146.67%
• 6 months: 17.89%
• Year to date: 83.59%
• 1 year: -28.42%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Medical Devices

About: Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Employees: 6